3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Glioblastoma
4
Small Cell Lung Carcinoma
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Gliosarcoma
3
Fallopian Tube Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Astrocytoma
3
Rectal Neoplasms
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Glioma
2
Colorectal Neoplasms
2
Brain Neoplasms
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Sezary Syndrome
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Oropharyngeal Neoplasms
1
Oligodendroglioma
1
Interventions
temsirolimus
1
sargramostim
1
ruxolitinib
1
rucaparib
1
pazopanib
1
olaparib
1
eltrombopag
1
cc-486
1
Surveys and Questionnaires
1
Nivolumab
1
Monatide (IMS 3015)
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Doxorubicin
1
Docetaxel
1
Diphenhydramine
1
Cytarabine
1
Cyclophosphamide
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pathologic Complete Response
×
veliparib
×
Clear all
No trials found.